farnesol and as 1411

farnesol has been researched along with as 1411 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Juster, D; Kloog, Y; Pinkas-Kramarski, R; Schokoroy, S	1
Goldshmit, Y; Kloog, Y; Pinkas-Kramarski, R; Trangle, SS	1

Other Studies

2 other study(ies) available for farnesol and as 1411

Article	Year
Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell death. PloS one, 2013, Volume: 8, Issue:9 Topics: Animals; Aptamers, Nucleotide; Carcinogenesis; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Farnesol; Humans; Immunoblotting; Immunohistochemistry; Mice; Mice, Nude; Microscopy, Fluorescence; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; ras Proteins; RNA-Binding Proteins; Salicylates	2013
Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma. Oncotarget, 2014, Sep-30, Volume: 5, Issue:18 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aptamers, Nucleotide; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Farnesol; Glioblastoma; Humans; Mice, Nude; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; Phosphorylation; ras Proteins; Receptor Cross-Talk; RNA-Binding Proteins; Salicylates; Signal Transduction; Time Factors; Tumor Burden	2014

Article

Year

Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell death.

PloS one, 2013, Volume: 8, Issue:9

Topics: Animals; Aptamers, Nucleotide; Carcinogenesis; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Farnesol; Humans; Immunoblotting; Immunohistochemistry; Mice; Mice, Nude; Microscopy, Fluorescence; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; ras Proteins; RNA-Binding Proteins; Salicylates

2013

Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.

Oncotarget, 2014, Sep-30, Volume: 5, Issue:18

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aptamers, Nucleotide; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Farnesol; Glioblastoma; Humans; Mice, Nude; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; Phosphorylation; ras Proteins; Receptor Cross-Talk; RNA-Binding Proteins; Salicylates; Signal Transduction; Time Factors; Tumor Burden

2014